Literature DB >> 9079597

Standardizing laparoscopic procedure time and determining the effect of patient age/gender and presence or absence of surgical residents during operation. A prospective multicenter trial.

L W Traverso1, K P Koo, K Hargrave, S W Unger, T S Roush, L L Swanstrom, M S Woods, J H Donohue, D J Deziel, I B Simon, E Froines, J Hunter, N J Soper.   

Abstract

BACKGROUND: Most of the expense of laparoscopic cholecystectomy (LC) is incurred while the patient is in the operating room (OR). Half of this operating room cost is equipment and the other half is personnel. What is an acceptable LC procedure time and how much variation is there? What are the effects of age, gender, and expertise on the mean LC procedure time?
METHODS: A prospective, multicenter gathering of LC procedure times and task component times was performed through the cooperative effort of members of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) at 11 hospitals. The effect of LC time of age, gender, and surgical resident was recorded.
RESULTS: The mean LC time for 359 cases was 73 +/- 28 min. The percent of this LC time for the following component tasks included: to place and remove trocars, 34%; total dissection time, 40%; intraoperative cholangiogram, 15%; and removing the gallbladder, 7%. Age and gender did not change LC time, but the presence of a surgical resident prolonged LC time from 53 to 79 min due to an increase in all LC component task times.
CONCLUSIONS: LC time was globally calibrated in 11 North American hospitals and was found to be affected by expertise but not by gender or age. The mean and standard deviation of LC time can be used for purposes of self-assessing quality performance.

Entities:  

Mesh:

Year:  1997        PMID: 9079597     DOI: 10.1007/s004649900331

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Surgical outcomes. What are they and why should they be measured?

Authors:  L W Traverso
Journal:  Surg Endosc       Date:  2000-02       Impact factor: 4.584

2.  Risk factors for intraoperative injury during cholecystectomy: an ounce of prevention is worth a pound of cure.

Authors:  L W Traverso
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  Automated high-frequency posture sampling for ergonomic assessment of laparoscopic surgery.

Authors:  J G Person; A J Hodgson; A G Nagy
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

4.  Analysis of the quality and efficiency in learning laparoscopic skills.

Authors:  K T den Boer; L T de Wit; P H Davids; J Dankelman; D J Gouma
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

5.  Opportunity costs of gastrointestinal endoscopic training in Canada.

Authors:  W T Depew; L C Hookey; S J Vanner; J A Louw; C E Lowe; M J Ropeleski; M J Beyak; A Lazarescu; W G Paterson
Journal:  Can J Gastroenterol       Date:  2010-12       Impact factor: 3.522

6.  Experimental assessment of a new mechanical endoscopic solosurgery system: Endofreeze.

Authors:  A Arezzo; M O Schurr; A Braun; G F Buess
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

7.  Smaller is better.

Authors:  S W Unger; J Paramo; M Perez-Izquierdo
Journal:  Surg Endosc       Date:  1998-12       Impact factor: 4.584

8.  Bile duct injury during laparoscopic cholecystectomy: results of a national survey.

Authors:  S B Archer; D W Brown; C D Smith; G D Branum; J G Hunter
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

9.  Telerobotic laparoscopic cholecystectomy: initial clinical experience with 25 patients.

Authors:  J Marescaux; M K Smith; D Fölscher; F Jamali; B Malassagne; J Leroy
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

10.  Micropuncture cholecystectomy vs conventional laparoscopic cholecystectomy: a randomized controlled trial.

Authors:  W G Ainslie; J A Catton; D Davides; S Dexter; J Gibson; M Larvin; M J McMahon; M Moore; S Smith; A Vezakis
Journal:  Surg Endosc       Date:  2003-03-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.